	Le Bénéfice D'Exploitation		Date
Amarin	USD -1.7M	8.47M	2025-09
Ardelyx	USD 4.67M	19.07M	2025-09
Baxter International	USD -214.2M	415.4M	2025-12
Bayer	EUR -543M	556M	2025-09
BioCryst Pharmaceuticals	USD -2.54M	10.23M	2024-12
Biogen	USD 659.6M	192.2M	2025-09
BioMarin Pharmaceutical	USD 198.39M	230.08M	2025-12
Emergent BioSolutions	USD -218M	69.9M	2023-06
Esperion Therapeutics	USD -16.03M	18.6M	2024-09
Gilead Sciences	USD 2.96B	551M	2025-12
GlaxoSmithKline	GBP 1.44B	1.35B	2025-12
Halozyme Therapeutics	USD -88.41M	306.33M	2025-12
Insmed	USD -249.71M	11.64M	2025-12
Ionis Pharmaceuticals	USD -215M	54.82M	2025-12
J&J	USD 5.59B	1.81B	2025-12
Lexicon Pharmaceuticals	USD -55.35M	10.02M	2024-06
Moderna	USD -857M	597M	2025-12
Omeros	USD -35.41M	23.75M	2024-09
Pfizer	USD 4.65B	3.99B	2025-12
PTC Therapeutics	USD -81.62M	85.11M	2025-12
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Sangamo BioSciences	USD -33.51M	12.77M	2024-06
Sarepta Therapeutics	USD -410.08M	347.2M	2025-12
Teva Pharmaceutical Industries	USD 487M	581M	2025-12
United Therapeutics	USD -14.6M	403.9M	2025-12
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12

United Therapeutics Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.